Skip to main content
Premium Trial:

Request an Annual Quote

People in the News: Arthur Levin, Dennis Ausiello

Premium

Miragen Therapeutics has named Arthur Levin as its new executive vice president of research and development.

In this role, Levin will be responsible for advancing the company's drug candidates into clinical development and for leading drug-discovery research efforts, according to Miragen.

Levin previously served as chief development officer and president of Santaris Pharma's US operations. Before that, he was senior vice president of development at Isis Pharmaceuticals.


Alnylam Pharmaceuticals has appointed Dennis Ausiello to its board of directors and scientific advisory board.

Ausiello is currently a professor of clinical medicine at Harvard Medical School and chief of medicine at Massachusetts General Hospital.

The Scan

Renewed Gain-of-Function Worries

The New York Times writes that the pandemic is renewing concerns about gain-of-function research.

Who's Getting the Patents?

A trio of researchers has analyzed gender trends in biomedical patents issued between 1976 and 2010 in the US, New Scientist reports.

Other Uses

CBS Sunday Morning looks at how mRNA vaccine technology could be applied beyond SARS-CoV-2.

PLOS Papers Present Analysis of Cervicovaginal Microbiome, Glycosylation in Model Archaea, More

In PLOS this week: functional potential of the cervicovaginal microbiome, glycosylation patterns in model archaea, and more.